Evidence map›Paper›PMID 38938678›Full record

ArticleJournal of extracellular biology2024

Extracellular vesicle biogenesis of three-dimensional human pluripotent stem cells in a novel Vertical-Wheel bioreactor.

Laureana Muok, Li Sun, Colin Esmonde, Hannah Worden, Cynthia Vied, Leanne Duke, Shaoyang Ma, Olivia Zeng, Tristan Driscoll, Sunghoon Jung and 1 more

Abstract read
In one paragraph

Article in Journal of extracellular biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Laureana MuokDepartment of Chemical and Biomedical Engineering, FAMU-FSU College of Engineering Florida State University Tallahassee Florida USA.
Li SunDepartment of Chemical and Biomedical Engineering, FAMU-FSU College of Engineering Florida State University Tallahassee Florida USA.ORCID https://orcid.org/0000-0001-8228-7487
Colin EsmondeDepartment of Chemical and Biomedical Engineering, FAMU-FSU College of Engineering Florida State University Tallahassee Florida USA.
Hannah WordenPBS Biotech Inc Camarillo California USA.
Cynthia ViedDepartment of Biomedical Sciences, College of Medicine Florida State University Tallahassee Florida USA.
Leanne DukeDepartment of Biomedical Sciences, College of Medicine Florida State University Tallahassee Florida USA.
Shaoyang MaDepartment of Chemical and Biomedical Engineering, FAMU-FSU College of Engineering Florida State University Tallahassee Florida USA.
Olivia ZengDepartment of Chemical and Biomedical Engineering, FAMU-FSU College of Engineering Florida State University Tallahassee Florida USA.
Tristan DriscollDepartment of Chemical and Biomedical Engineering, FAMU-FSU College of Engineering Florida State University Tallahassee Florida USA.
Sunghoon JungPBS Biotech Inc Camarillo California USA.
Yan LiDepartment of Chemical and Biomedical Engineering, FAMU-FSU College of Engineering Florida State University Tallahassee Florida USA.ORCID https://orcid.org/0000-0002-5938-8519

Funding

Engineering Extracellular Vesicles of Human Brain Organoids for Stroke TherapyR01NS125016 · NINDS · FLORIDA STATE UNIVERSITY · PI Yan Li · 2022 to 2026
$1.8M
NINDS NIH HHS R01 NS125016
6 · The paper itself

Abstract

Extracellular vesicles (EVs) secreted by human-induced pluripotent stem cells (hiPSCs) have great potential as cell-free therapies in various diseases, including prevention of blood-brain barrier senescence and stroke. However, there are still challenges in pre-clinical and clinical use of hiPSC-EVs due to the need for large-scale production of a large quantity. Vertical-Wheel bioreactors (VWBRs) have design features that allow the biomanufacturing of hiPSC-EVs using a scalable aggregate or microcarrier-based culture system under low shear stress. EV secretion by undifferentiated hiPSCs expanded as 3-D aggregates and on Synthemax II microcarriers in VWBRs were investigated. Additionally, two types of EV collection media, mTeSR and HBM, were compared. The hiPSCs were characterized by metabolite and transcriptome analysis as well as EV biogenesis markers. Protein and microRNA cargo were analysed by proteomics and microRNA-seq, respectively. The

Indexed as

aggregatesextracellular vesicleshuman pluripotent stem cellsmicrocarriersmulti‐omicsVertical‐Wheel bioreactor

Identifiers

PMID38938678
PMCPMC11080838

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.